Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2026-09 Cobimetinib
Description
The participating funds aim to conclude discount contracts in accordance with § 130c para. 1 SGB V with all suitable pharmaceutical companies for the active substance Cobimetinib. The contract is concluded within the framework of the Open-House-Originale procedure of the participating funds: Individual negotiations on contract contents are not conducted, uniform conditions apply. The participating health insurance funds do not guarantee exclusivity to individual contracting partners. The contract period is a maximum of 24 months, starting on 01.11.2026. The contract ends at the latest on 31.10.2028, regardless of the date of the contract conclusion. In the event of patent expiry/expiry of market exclusivity before the above end date, the contract expires automatically at the end of the month of patent expiry/market exclusivity. Joining this Open-House-Originale procedure is possible at any time during the contract period. All further information can be found in the participation and contract documents.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Mammography devices – Röntgenanlage für Mammographie
Zentralklinik Ostfriesische Meere gGmbHGermanyMammography devicesDeadline in 29 daysPublished on Nov 19, 2026
Germany – Miscellaneous medical devices and products – VE 473.05 105 Deckenversorgungseinheiten Medien
Universitätsklinikum HeidelbergGermanyMiscellaneous medical devices and productsInstallation services of medical equipmentDeadline in 27 daysPublished on Nov 19, 2026
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
BARMER Beschaffung und VergabeGermanyPharmaceutical productsDeadline in 618 daysPublished on Nov 19, 2026
Germany – Medical equipments, pharmaceuticals and personal care products – Absaugung, Invasive Blutdruckmessung und Regionalanästhesie
EK-UNICO GmbHGermanyMedical equipments, pharmaceuticals and personal care productsVenepuncture, blood sampling devicesAnaesthesia and resuscitationDeadline in 30 daysPublished on Nov 19, 2026